TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 173 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $240 | -58.0% | 26,832 | -27.8% | 0.00% | – |
| Q2 2023 | $571 | -18.9% | 37,151 | +18.7% | 0.00% | – |
| Q1 2023 | $704 | +15.4% | 31,290 | +7.9% | 0.00% | – |
| Q4 2022 | $610 | -99.9% | 28,998 | -6.4% | 0.00% | – |
| Q3 2022 | $764,000 | +17.4% | 30,974 | +15.3% | 0.00% | – |
| Q2 2022 | $651,000 | +53.2% | 26,868 | +63.0% | 0.00% | – |
| Q1 2022 | $425,000 | -3.6% | 16,486 | +16.1% | 0.00% | – |
| Q4 2021 | $441,000 | – | 14,197 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,084,300 | $15,820,000 | 3.32% |
| ARMISTICE CAPITAL, LLC | 5,748,000 | $83,863,000 | 1.50% |
| RA Capital Management | 5,614,428 | $81,915,000 | 1.32% |
| Krensavage Asset Management, LLC | 140,000 | $2,043,000 | 0.69% |
| CM Management, LLC | 60,000 | $875,000 | 0.63% |
| Altium Capital Management LP | 170,484 | $2,487,000 | 0.58% |
| HighVista Strategies LLC | 53,498 | $781,000 | 0.55% |
| Sio Capital Management, LLC | 150,000 | $2,189,000 | 0.54% |
| MANGROVE PARTNERS IM, LLC | 295,037 | $4,305,000 | 0.44% |
| Rock Springs Capital Management LP | 1,494,164 | $21,800,000 | 0.43% |